Close menu




October 7th, 2026 | 08:50 CEST

Takeover Battle Intensifies: BASF, Evonik, Gerresheimer and Phenom Resources

  • Gold
  • Vanadium
  • chemicals
  • Takeover
Photo credits: AI-Generated with ChatGPT

The takeover battle surrounding BASF and Evonik is intensifying, and politicians are now getting involved as well. The state government is demanding job guarantees, while the leader of the SPD parliamentary group in North Rhine-Westphalia has voiced criticism and called on Minister President Hendrik Wüst to step up his efforts and provide greater clarity. Phenom Resources is a hot stock with takeover potential. The Canadian company is focused on gold and vanadium projects in the US state of Nevada. Its gold and copper assets are set to be spun off—but could a strategic partner make a move instead? Gerresheimer was already in the crosshairs of financial investors back in 2025. Since the failed takeover attempt, however, things have been relatively quiet. The company is currently restructuring and streamlining its business. That could eventually put it back on potential buyers' radar.

time to read: 5 minutes | Author: Fabian Lorenz
ISIN: PHENOM RESOURCES CORP | CA71743P1071 | TSXV: PHNM , GERRESHEIMER AG | DE000A0LD6E6 , EVONIK INDUSTRIES NA O.N. | DE000EVNK013 , BASF SE NA O.N. | DE000BASF111

Table of contents:


    Phenom Resources: A Hot Stock with Takeover Potential

    Phenom Resources is an exciting stock with a strong partner and significant takeover potential. The Vancouver-based Canadian exploration and technology company is still relatively unknown in Europe. That could change soon. The exploration company is focused on gold and vanadium projects in the US state of Nevada. Its gold portfolio includes the four projects Carlin, Dobbin, King Solomon and Crescent Valley. For its exploration efforts, Phenom relies on an experienced team of geologists led by Dave Mathewson, who has already discovered several gold deposits. In 2026, the company is focused on drilling at Dobbin, King Solomon and Crescent Valley. In addition, the company plans to spin off its gold and copper operations into a separate entity and offer its shareholders a stake in it.

    In the vanadium sector, Phenom claims to hold the largest and highest-grade primary vanadium resource in North America. A preliminary economic assessment for the project is already available. Further studies are intended to identify opportunities to reduce capital and operating costs. Vanadium is used, among other things, in stationary battery storage systems. Through a 5% stake in the Japanese battery developer MK Plus, Phenom is also involved in the further development of related storage technologies. In addition, the company is developing patented processes to extract vanadium and nickel and is seeking funding and industry partnerships to support this work.

    Phenom already has SSR Mining, a gold-focused mining group, as a shareholder and project partner. SSR Mining could also play a major role in the planned spin-off of the gold and copper operations. Most recently, SSR Mining secured a 15% stake in Phenom Resources' Dobbin project for USD 4 million. SSR's investment will be directed entirely toward the project's further development. Once these funds are exhausted, both partners are to finance further exploration and development costs in proportion to their respective stakes. SSR is already Phenom's largest shareholder. According to Phenom, SSR Mining has provided approximately USD 11 million to date. The funds are intended to support the planned exploration work well into next year. In addition to financing, Phenom expects additional technical support from its new project partner.

    Gerresheimer Sells Subsidiary: Will It Soon Be Acquired Itself?

    Gerresheimer was already the focus of financial investors back in 2025. A consortium consisting of KKR and Warburg Pincus is said to have offered just under EUR 90 per share of the struggling group at that time. After KKR withdrew, the talks were terminated in July 2025. Currently, there are no confirmed new negotiations regarding a sale of the entire group. Instead, the focus is on selling individual business units to Apax and reducing associated debt. However, this streamlining is making Gerresheimer attractive to buyers once again.

    mwb research currently sees no takeover potential, nor any upside potential for the share price. The analysts expect more clarity with the final half-year results and reaffirm their "Sell" recommendation with a price target of EUR 20.

    The preliminary figures for the second quarter of 2026 at least suggest that Gerresheimer is getting back on track operationally. According to these figures, revenue rose by EUR 55 million from the previous quarter to EUR 578 million. Adjusted EBITDA increased by EUR 35 million to EUR 102 million. Compared to the same quarter last year, however, both revenue and earnings remained down. Adjusted EBITDA was 19% lower. Analysts therefore see a stabilization, but not yet a return to previous levels of profitability.

    The sale of Centor, which was completed on October 1, is intended to accelerate debt reduction and lower the risks associated with the Group's restructuring. Centor accounts for about half of the total enterprise value of EUR 1.5 billion agreed upon for Centor and PPP. The PPP sale is expected to be completed in the first half of 2027, after which the Group plans a more comprehensive refinancing. However, analysts still lack details on the exact net proceeds and the remaining group's future earnings base. Until they receive this information, they are maintaining their "Sell" recommendation.

    BASF and Evonik: Takeover Standoff Intensifies

    The potential acquisition of Evonik by BASF is facing political reservations in North Rhine-Westphalia. On Monday, the state government emphasized that the jobs and independent development of the Essen-based chemical company must not be called into question. Previously, Jochen Ott, leader of the SPD parliamentary group in North Rhine-Westphalia, had already voiced criticism. He sees employment and industrial value creation in the Ruhr region as being at risk and is calling on Minister President Hendrik Wüst to intervene. Through Wüst's seat on the board of trustees of the RAG Foundation, the state government wields influence over Evonik's largest shareholder. The SPD is also demanding information about any preliminary discussions between BASF and the state government.

    The merger of the two German chemical giants remains up in the air. According to "Reuters", Evonik has rejected an initial proposal from BASF of approximately EUR 10.3 billion, or EUR 22.15 per share, as too low. BASF has officially confirmed the exploratory talks but has not yet reported an agreement. The RAG Foundation, which holds just under 44% of Evonik's shares, plays a key role. It has since stated that, in principle, it could sell its entire stake. This means a merger remains possible, but no public agreement on the price and terms of a transaction exists yet.
    The stock market does not yet seem to believe the takeover will happen. Evonik shares are currently trading below EUR 21.


    The takeover saga involving BASF and Evonik is likely to drag on for some time. Whether shareholders should position themselves accordingly, however, is questionable. Both companies are facing problems, and together these are unlikely to diminish. Phenom Resources is an exciting hot stock with takeover potential. With gold and vanadium, the company is active in promising sectors. The focus on vanadium and the spin-off of the gold and copper operations could lead to a re-rating of the stock. And then, of course, there is the potential buyer. That buyer is already on board. Gerresheimer remains a speculative stock, even if there is light at the end of the tunnel.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Fabian Lorenz

    For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.

    About the author



    Related comments:

    Commented by Carsten Mainitz on October 7th, 2026 | 08:40 CEST

    Spot the Next Stock Catalyst Early: Key Milestones for Lahontan Gold, Evotec and Deutz

    • Mining
    • Gold
    • Silver
    • Commodities
    • Defense
    • geopolitics
    • Biotech

    Get in before the stock takes off! The key is to identify the trigger for the next share-price move early enough. Lahontan Gold is working to restart a historic gold mine in Nevada and recently made an attractive acquisition. Biotech company Evotec is fighting to turn its operations around and rebuild investor confidence. Deutz is expanding its industrial business into energy and defense, taking the company into new dimensions of growth. What does this mean for investors? Where are the most compelling opportunities for stock pickers?

    Read

    Commented by Matthias Schomber on October 6th, 2026 | 07:30 CEST

    From Legacy Issues to Growth Opportunities: Why BASF, Bayer and Zefiro Methane Are Worth Watching

    • methane
    • OrphanWells
    • Pharma
    • chemicals

    Created and Published on Behalf of Zefiro Methane Corp.

    BASF is working its way through a cost-cutting program and continues to attract investors with a strong dividend. In addition, the chemical giant plans to acquire its competitor Evonik. This strategic acquisition is intended to significantly expand its market power during challenging times. Whether it succeeds, however, remains to be seen. Bayer, too, is undergoing a painful restructuring to address its legacy issues and reduce debt, but offers bold investors attractive turnaround potential—provided much of this effort succeeds. The dynamics across the Atlantic are quite different. There, Zefiro Methane is turning the remediation of abandoned oil and gas wells in North America into a profitable growth business, with strong sales and a promising chart pattern.

    Read

    Commented by Fabian Lorenz on October 6th, 2026 | 07:25 CEST

    Gold Mining Stocks: Time to Buy? Barrick Mining, B2Gold and Desert Gold in Focus

    • Mining
    • Gold
    • Africa
    • Commodities
    • Investments

    Should you buy gold mining stocks now? Gold expert Markus Bußler sees the recent pullback as an attractive entry opportunity. After a rally of about 50%, the GDX mining ETF had fallen about 18% from its high. This has brought it back into the technical buy zone between approximately USD 84 and USD 88. At these levels, the expert believes the risk-reward ratio once again favours buying. A similar technical setup had already led him to a positive assessment in July. The market subsequently posted strong gains. The current negative sentiment therefore does not deter him. Stocks such as Barrick Mining, B2Gold and Desert Gold could benefit from this development.

    Read